Page 81 - Sohini Das

Apollo's digital platform move may fuel consolidation, benefit consumers

Apollo will merge its online and offline pharmacy businesses (excluding hospital pharmacies) and telemedicine verticals into a single entity called Apollo HealthCo

Herd immunity is both mystical and mythical: NTAGI chairman N K Arora

Herd immunity works when immunised and unimmunised individuals are mixed in a true random process and around 80 per cent are immunised, said Arora

Private hospitals to order Covid-19 jabs on CoWin platform from July

Vaccine makers see logistics issues in distributing to smaller hospitals

Bharat Biotech's Covaxin shows over 77% efficacy in phase 3 trials

The vaccine has shown an efficacy rate of 93 per cent against severe disease and 60 per cent against asymptomatic Covid-19

Pfizer in the final stages to ink Covid-19 vaccine deal with Centre

Sources close to the developments had indicated earlier that the price for India could be below $10 per dose, or the lowest in the world

Covid-19 vaccination score tops 8 million as new rules take effect

Monday number 2.5 times the daily average

Full Covid-19 vaccination of adults will take 7 months if pace doubled

There are 865 million adults who require vaccination to meet the December target

Only 0.05% fully vaccinated healthcare workers got severe Covid: Fortis

Study covered over 16,000 healthcare workers across Fortis hospitals in India

Exploring windows to enhance shareholder value: Thyrocare Technologies

Thyrocare's market capitalisation is around Rs 6,916 crore. The deal thus could be for a shareholding in the firm

How Biological E could emerge as game changer in India's vaccine race

Company scales up its ambition after government advanced it Rs 1,500 crore for 300 million doses of its vaccine candidate.

Covid-19 vaccine pricing accounts for last-mile delivery, say firms

The cost of logistics is built into the final price of the vaccine, especially when supplying to the private sector

Covaxin's final product has no calf serum, Bharat Biotech and govt clarify

Health ministry says this has been used for decades in Polio, Rabies, and Influenza vaccines, is neither used in growth of SARS CoV2 virus nor in the final formulation

Decoded: Delta, Delta Plus variants and their response to vaccines

While virologists say theoretically the vaccine that works on Delta should work on the Delta Plus variant as well, more research is needed

Covid-19 vaccine Covaxin at Rs 150 not sustainable: Bharat Biotech

Higher price in private market required to offset part of the costs, argues firm

Govt panel confirms first death in India after Covid-19 vaccination

68-year-old man was administered Covishield on Mar 8

Novavax Covid-19 shot shows 90% efficacy, Serum Institute starts production

On track to make 100 mn doses per month by Q3 of 2021

Covid-19 drugs portfolio boost domestic sales of companies in FY21

Chronic therapy areas like cardiac and anti-diabetic have maintained their growth rates during FY21 despite a washout in the first quarter

Zydus Cadila may soon seek emergency use authorisation for Covid-19 vaccine

This could also be India's first vaccine for children aged 12 years and above as the company has conducted trials on the age group. The decision, however, lies with the regulator

Covid-19 pandemic: Bharat Biotech's Covaxin set for clinical trials in US

FDA asks Bharat Bio's US partner Ocugen to apply for full authorisation

Bharat Biotech to conduct additional clinical trials for USFDA nod

Timelines will be delayed; firm has received EUSs from 14 other countries